C-ERBB-2, EGF RECEPTOR P53 AND PCNA - THE PROGNOSTIC-SIGNIFICANCE OF NEW FACTORS FOR THE LYMPH NODE-NEGATIVE CARCINOMA OF THE BREAST

Citation
I. Schonborn et al., C-ERBB-2, EGF RECEPTOR P53 AND PCNA - THE PROGNOSTIC-SIGNIFICANCE OF NEW FACTORS FOR THE LYMPH NODE-NEGATIVE CARCINOMA OF THE BREAST, Geburtshilfe und Frauenheilkunde, 55(10), 1995, pp. 566-571
Citations number
24
Categorie Soggetti
Obsetric & Gynecology
ISSN journal
00165751
Volume
55
Issue
10
Year of publication
1995
Pages
566 - 571
Database
ISI
SICI code
0016-5751(1995)55:10<566:CERPAP>2.0.ZU;2-I
Abstract
In 216 breast cancer patients, the prognostic value of current biologi cal factors (c-erbB-2, EGF-receptor, p53, PCNA-proliferative fraction) was compared with that of conventionally histomorphologic features (h istologic type, histologic grade, tumour size, hormonal receptor statu s), After a 66 (6-109) months' median follow-up survival was significa ntly correlated with histological grade (p = 0.014) and PCNA-prolivera tive activity (p = 0.015). The prognostic influence of oestrogen recep tor (ER)- and progesteron receptor (PR-)status achieved borderline sig nificance (ER/p = 0.07; PR/p = 0.05). Neither c-erbB-2, EGF-R, p53 nor any of the other factors showed any correlation to survival. In the m ultivariate analysis, histological grade was revealed as the only inde pendent prognostic factor. The prognostic value of PCNA was second to histological grade and if grade was excluded from the analysis, PCNA-e xpression became the only independent factor. Thus, in individual case s the PCNA-proliferative fraction could help the clinician to decide o n the therapy.